Protein kinase D2 is a crucial regulator of tumour cell - Endothelial cell communication in gastrointestinal tumours

Gut

Volumn 59, Issue 10, 2010, Pages 1316-1330

  Azoitei, Ninel ^a   Pusapati, Ganesh Varma ^a   Kleger, Alexander ^a,b   Möller, Peter ^a   Küfer, Rainer ^a   Genze, Felicitas ^a   Wagner, Martin ^a   Van Lint, Johan ^c   Carmeliet, Peter ^d   Adler, Guido ^a   Seufferlein, Thomas ^a,e  

^a UNIVERSITY OF ULM   (Germany)

^b Max Planck Research Group on Stem Cell Aging   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d Vesalius Research Center (VRC)   (Belgium)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; PROTEIN KINASE; PROTEIN KINASE D1; PROTEIN KINASE D2; PROTEIN KINASE D3; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NR4; UNCLASSIFIED DRUG; VASCULOTROPIN 165; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL MIGRATION; CELL PROLIFERATION; CHORIOALLANTOIS; COLORECTAL CANCER; ENDOTHELIUM CELL; ENZYME ACTIVATION; GASTROINTESTINAL TUMOR; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; STOMACH CANCER; STOMACH TUMOR; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CHICK EMBRYO; COCULTURE; ENZYMOLOGY; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; VASCULAR ENDOTHELIUM; VASCULARIZATION; XENOGRAFT;

ANIMALS; CELL COMMUNICATION; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GASTROINTESTINAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PROTEIN KINASES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957196554     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.206813     Document Type: Article

References (54)

1. Semenza GL. HIF-1 and tumour progression: pathophysiology and therapeutics. Trends Mol Med 2002;8:S62-7.
2. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
3. Liu Y, Cox SR, Morita T, et al. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 1995;77:638-43.
4. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
5. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 2002;29:10-14.
6. Wong C, Jin ZG. Protein Kinase C-dependent Protein Kinase D Activation Modulates ERK Signal Pathway and Endothelial Cell Proliferation by Vascular Endothelial Growth Factor. The Journal of biological chemistry 2005;280:33262-9.
7. Qin L, Zeng H, Zhao D. Requirement of protein kinase D tyrosine phosphorylation for VEGF-A165-induced angiogenesis through its interaction and regulation of phospholipase Cgamma phosphorylation. The Journal of biological chemistry 2006;281:32550-8.
8. Evans IM, Britton G, Zachary IC. Vascular endothelial growth factor induces heat shock protein (HSP) 27 serine 82 phosphorylation and endothelial tubulogenesis via protein kinase D and independent of p38 kinase. Cell Signal 2008;20:1375-84.
9. Ha CH, Wang W, Jhun BS, et al. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis. The Journal of biological chemistry 2008;283:14590-9.
10. Hao Q, Wang L, Zhao ZJ, et al. Identification of protein kinase D2 as a pivotal regulator of endothelial cell proliferation, migration, and angiogenesis. J biological chemistry 2009;284:799-806.
11. Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome. Science 2002;298:1912-34.
12. Rykx A, De Kimpe L, Mikhalap S, et al. Protein kinase D: a family affair. FEBS Lett 2003;546:81-6.
13. Storz P. Mitochondrial ROS-radical detoxification, mediated by protein kinase D. Trends Cell Biol 2007;17:13-18.
14. Zugaza JL, Sinnett-Smith J, Van Lint J, et al. Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. Embo J 1996;15:6220-30.
15. Sturany S, Van Lint J, Gilchrist A, et al. Mechanism of activation of protein kinase D2(PKD2) by the CCK(B)/gastrin receptor. The Journal of biological chemistry 2002;277:29431-6.
16. Prigozhina NL, Waterman-Storer CM. Protein kinase D-mediated anterograde membrane trafficking is required for fibroblast motility. Curr Biol 2004;14:88-98.
17. Eiseler T, Schmid MA, Topbas F, et al. PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration. FEBS Lett 2007;581:4279-87.
18. Bowden ET, Barth M, Thomas D, et al. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999;18:4440-9.
19. De Kimpe L, Janssens K, Derua R, et al. Characterization of cortactin as an in vivo protein kinase D substrate: interdependence of sites and potentiation by Src. Cell Signal 2009;21:253-63.
20. Eiseler T, Doppler H, Yan IK, et al. Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot. Nat Cell Biol 2009;11:545-56.
21. Chen J, Deng F, Singh SV, et al. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. Cancer Res 2008;68:3844-53.
22. Sharlow ER, Giridhar KV, LaValle CR, et al. Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone. J biological chemistry 2008;283:33516-26.
23. Mihailovic T, Marx M, Auer A, et al. Protein kinase D2 mediates activation of nuclear factor kappaB by Bcr-Abl in Bcr-Abl+ human myeloid leukemia cells. Cancer Res 2004;64:8939-44.
24. Peterburs P, Heering J, Link G, et al. Protein kinase D regulates cell migration by direct phosphorylation of the cofilin phosphatase slingshot 1 like. Cancer Res 2009;69:5634-8.
25. Sturany S, Van Lint J, Muller F, et al. Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases. J biological chemistry 2001;276:3310-18.
26. Yuan J, Rozengurt E. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells. J Cell Biochem 2008;103:648-62.
27. Norrby K. In vivo models of angiogenesis. J Cell Mol Med 2006;10:588-612.
28. Kuefer R, Hofer MD, Altug V, et al. Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. Br J Cancer 2004;90:535-41.
29. Vogler M, Giagkousiklidis S, Genze F, et al. Inhibition of clonogenic tumour growth: a novel function of Smac contributing to its antitumour activity. Oncogene 2005;24:7190-202.
30. Matthews SA, Liu P, Spitaler M, et al. Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes. Mol Cell Biol 2006;26:1569-77.
31. Korff T, Kimmina S, Martiny-Baron G, et al. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J 2001;15:447-57.
32. Wenger A, Stahl A, Weber H, et al. Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng 2004;10:1536-47.
33. Svasti S, Suwanmanee T, Fucharoen S, et al. RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice. Proc Natl Acad Sci U S A 2009;106:1205-10.
34. Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009;324:1457-61.
35. Sipos B, Weber D, Ungefroren H, et al. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study. International journal of cancer 2002;102:592-600.
36. Duffy JP, Eibl G, Reber HA, et al. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer 2003;2:12.
37. Young TA, Wang H, Munk S, et al. Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent. Experimental eye research 2005;80:651-62.
38. Ijichi A, Sakuma S, Tofilon PJ. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Glia 1995;14:87-93.
39. Choi JW, Park SC, Kang GH, et al. Nur77 activated by hypoxia-inducible factor- 1alpha overproduces proopiomelanocortin in von Hippel-Lindau-mutated renal cell carcinoma. Cancer Res 2004;64:35-9.
40. Zeng H, Qin L, Zhao D, et al. Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med 2006;203:719-29.
41. Parra M, Kasler H, McKinsey TA, et al. Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. The Journal of biological chemistry 2005;280:13762-70.
42. Dequiedt F, Van Lint J, Lecomte E, et al. Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J Exp Med 2005;201:793-804.
43. von Blume J, Knippschild U, Dequiedt F, et al. Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2. EMBO J 2007;26:4619-33.
44. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005;69 (Suppl 3):4-10.
45. Ristich VL, Bowman PH, Dodd ME, et al. Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis. Br J Dermatol 2006;154:586-93.
46. Hao Q, Wang L, Tang H. Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells. Am J Physiol Cell Physiol 2009;296:C821-7.
47. Yoo YG, Yeo MG, Kim DK, et al. Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1alpha. J biological chemistry 2004;279:53365-73.
48. Melillo G. Targeting hypoxia cell signaling for cancer therapy. Cancer Metastasis Rev 2007;26:341-52.
49. Ziello JE, Jovin IS, Huang Y. Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med 2007;80:51-60.
50. Loges S, Mazzone M, Hohensinner P, et al. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell 2009;15:167-70.
51. Paez-Ribes M, Allen E, Hudock J, et al. Antiangiogenic therapy elicits malignant progression of tumours to increased local invasion and distant metastasis. Cancer Cell 2009;15:220-31.
52. Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008;8:592-603.
53. Casanovas O, Hicklin DJ, Bergers G, et al. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumours. Cancer Cell 2005;8:299-309.
54. Relf M, LeJeune S, Scott PA, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumour growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997;57:963-9.